ANRO (ANRO) Stock Price & Analysis
ANRO (ANRO) fell 2.33% to USD 35.55 as of September 8, 2026 at 05:00 UTC, according to Nexqual real-time market data.
ANRO last closed at USD 35.55; the session ranged USD 35.45–36.98 on volume of 269,934 shares. Market capitalization is —, with a 52-week range of USD 3.5–37.48 (NYQ). Source: Nexqual, September 8, 2026 at 05:00 UTC.
Key Statistics (as of September 8, 2026 at 05:00 UTC)
| Price | USD 35.55 |
|---|---|
| Change | ▼ 2.33% (down) |
| Previous Close | USD 35.55 |
| Open | USD 35.55 |
| Day Range | USD 35.45 – 36.98 |
| 52-Week Range | USD 3.5 – 37.48 |
| Volume | 269,934 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ANRO)
Nexqual's technical model rates ANRO "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 05:00 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 63.9 (neutral) |
| vs SMA50 | Above (USD 29.91) |
| MACD | 2.01 (positive) |
From ANRO's Latest SEC 10-K Filing (filed 2026-03-16)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KYTX | Kyverna Therapeutics, Inc. | USD 8.25 | ▼ 4.24% |
| AVBP | ArriVent BioPharma, Inc. | USD 30.95 | ▲ 1.44% |
| ARTV | Artiva Biotherapeutics, Inc. | USD 11.19 | ▼ 1.06% |
| RAPP | Rapport Therapeutics, Inc. | USD 45.77 | ▼ 6% |
| CGON | CG Oncology, Inc. | USD 74.67 | ▲ 0.11% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:00 UTC. This page is informational and not investment advice.